CytomX Therapeutics
CTMX
CTMX
70 hedge funds and large institutions have $48.1M invested in CytomX Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.84% less ownership
Funds ownership: 65.53% → 59.69% (-5.8%)
20% less capital invested
Capital invested by funds: $60.4M → $48.1M (-$12.3M)
Holders
70
Holding in Top 10
–
Calls
$36K
Puts
$5K
Top Buyers
| 1 | +$2.73M | |
| 2 | +$909K | |
| 3 | +$836K | |
| 4 |
Millennium Management
New York
|
+$681K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$453K |
Top Sellers
| 1 | -$5.7M | |
| 2 | -$3.54M | |
| 3 | -$1.08M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$782K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$515K |